"Cyclin B1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclin B subtype that colocalizes with MICROTUBULES during INTERPHASE and is transported into the CELL NUCLEUS at the end of the G2 PHASE.
| Descriptor ID |
D056744
|
| MeSH Number(s) |
D12.644.360.262.120.100 D12.776.167.218.120.100 D12.776.476.262.120.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclin B1".
Below are MeSH descriptors whose meaning is more specific than "Cyclin B1".
This graph shows the total number of publications written about "Cyclin B1" by people in this website by year, and whether "Cyclin B1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclin B1" by people in Profiles.
-
Alternative cleavage and polyadenylation of the Ccnb1 mRNA defines accumulation of cyclin protein during the meiotic cell cycle. Nucleic Acids Res. 2024 Feb 09; 52(3):1258-1271.
-
Clinical Significance of Cyclin Expression Profiling in Ocular Surface Squamous Neoplasia. Appl Immunohistochem Mol Morphol. 2022 03 01; 30(3):197-203.
-
LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. Carcinogenesis. 2020 03 13; 41(1):111-121.
-
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell. 2018 03 22; 173(1):104-116.e12.
-
Targeting Aberrant p70S6K Activation for Estrogen Receptor-Negative Breast Cancer Prevention. Cancer Prev Res (Phila). 2017 Nov; 10(11):641-650.
-
Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry. Cell Cycle. 2016; 15(5):730-9.
-
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins. Mol Oncol. 2013 Jun; 7(3):704-18.
-
A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-? signaling pathways. BMC Complement Altern Med. 2013 Feb 15; 13:33.
-
Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma. Cell Cycle. 2012 Jul 15; 11(14):2729-38.
-
Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prev Res (Phila). 2012 Aug; 5(8):1036-43.